Laboratory monitoring of high-dose factor VIIa therapy.
Maureane
M
Hoffman
D000925:Anticoagulants / Q000009:adverse effects*; D005167:Factor VII / Q000627:therapeutic use*; D015942:Factor VIIa; D006470:Hemorrhage / Q000517:prevention & control*; D008991:Monitoring, Physiologic; D011994:Recombinant Proteins / Q000627:therapeutic use*
D000925:Anticoagulants; D011994:Recombinant Proteins; D005167:Factor VII; C103587:recombinant FVIIa; D015942:Factor VIIa